SC-68376, identified by its CAS number 318480-82-9, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound typically exhibits a defined molecular structure, which influences its solubility, stability, and interaction with biological targets. SC-68376 is often studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are crucial for understanding its behavior in biological systems. Additionally, its safety profile and potential side effects are evaluated through preclinical and clinical studies. As with many compounds in drug development, ongoing research aims to elucidate its mechanism of action and optimize its therapeutic potential while minimizing adverse effects. Overall, SC-68376 represents a significant focus within pharmaceutical research, reflecting the broader efforts to develop targeted therapies for various health conditions.

SC-68376

318480-82-9: SC-68376, identified by its CAS number 318480-82-9, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound typically exhibits a defined molecular structure, which influences its solubility, stability, and interaction with biological targets. SC-68376 is often studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are crucial for understanding its behavior in biological systems. Additionally, its safety profile and potential side effects are evaluated through preclinical and clinical studies. As with many compounds in drug development, ongoing research aims to elucidate its mechanism of action and optimize its therapeutic potential while minimizing adverse effects. Overall, SC-68376 represents a significant focus within pharmaceutical research, reflecting the broader efforts to develop targeted therapies for various health conditions.

<p>SC-68376 is a potent, reversible, cell-permeable, ATP-competitive, and selective inhibitor of p38 MAP kinase.</p>

CAS 318480-82-9

SC-68376

SC-68376

Ref: TM-T28702